PuSH - Publication Server of Helmholtz Zentrum München

33 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Pennells, L.* et al.: Equalization of four cardiovascular risk algorithms after systematic recalibration: Individual-participant meta-analysis of 86 prospective studies. Eur. Heart J. 40, 621-631 (2019)
2.
Mahajan, A.* et al.: Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat. Genet. 50, 559-571 (2018)
3.
Ferrario, M.M.* et al.: Determinants of social inequalities in stroke incidence across Europe: A collaborative analysis of 126 635 individuals from 48 cohort studies. J. Epidemiol. Community Health 71, 1210-1216 (2017)
4.
Flannick, J.* et al.: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. Sci. Data 4:170179 (2017)
5.
Manning, A.* et al.: A low-frequency inactivating Akt2 variant enriched in the Finnish population is associated with fasting insulin levels and type 2 diabetes risk. Diabetes 66, 2019-2032 (2017)
6.
Scott, R.A.* et al.: An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes 66, 2888-2902 (2017)
7.
Skaaby, T.* et al.: Investigating the causal effect of smoking on hay fever and asthma: A Mendelian randomization meta-analysis in the CARTA consortium. Sci. Rep. 7:2224 (2017)
8.
Veronesi, G.* et al.: Combined effect of educational status and cardiovascular risk factors on the incidence of coronary heart disease and stroke in European cohorts: Implications for prevention. Eur. J. Prev. Cardiol. 24, 437-445 (2017)
9.
Waldeyer, C.* et al.: Lipoprotein(a) and the risk of cardiovascular disease in the European population: Results from the BiomarCaRE consortium. Eur. Heart J. 38, 2490-2498 (2017)
10.
Blankenberg, S.* et al.: Troponin I and cardiovascular risk prediction in the general population: The BiomarCaRE consortium. Eur. Heart J. 37, 2428-2437 (2016)
11.
Fuchsberger, C.* et al.: The genetic architecture of type 2 diabetes. Nature 536, 41-47 (2016)
12.
Kilpeläinen, T.O.* et al.: Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Nat. Commun. 7:10494 (2016)
13.
Lu, Y.* et al.: New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. Nat. Commun. 7:10495 (2016)
14.
Scott, R.A.* et al.: A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. Sci. Transl. Med. 8:341ra76 (2016)
15.
Veronesi, G.* et al.: Educational class inequalities in the incidence of coronary heart disease in Europe. Heart 102, 958-965 (2016)
16.
Gaulton, K.J.* et al.: Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat. Genet. 47, 1415-1425 (2015)
17.
Kato, N.* et al.: Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat. Genet. 47, 1282-1293 (2015)
18.
Mahajan, A.* et al.: Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. PLoS Genet. 11:e1004876 (2015)
19.
Winkler, T.W.* et al.: The influence of age and sex on genetic associations with adult body size and shape: A large-scale genome-wide interaction study. PLoS Genet. 11:e1005378 (2015)
20.
Flannick, J.* et al.: Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat. Genet. 46, 357-363 (2014)